Celularity Inc. President Andrew Pecora to Resign Effective August 31, 2022

Celularity Inc

President Andrew L. Pecora, M.D., F.A.C.P., notified board of resignation on July 14, 2022.
Resignation effective August 31, 2022, not related to any disagreement with Celularity.
Celularity expects to enter into a consulting agreement with Dr. Pecora for transition.
Dr. Pecora will also serve as co-Chair of Celularity's Scientific Advisory Board.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Andrew L. Pecora

President

CELU · Celularity Inc

Effective: 2022-08-31
Filed: July 20, 2022, 7:59 PM ET

On July 14, 2022, Andrew L. Pecora, M.D., F.A.C.P., President of Celularity Inc., or Celularity, notified the board of directors of his decision to resign as President effective as of August 31, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Andrew L. Pecora resigned as President at Celularity Inc.

Action: resigned
Role: President

Exact text from the filing

On July 14, 2022, Andrew L. Pecora, M.D., F.A.C.P., President of Celularity Inc., or Celularity, notified the board of directors of his decision to resign as President effective as of August 31, 2022.

View on SEC.gov

Celularity Inc filing history →

Source: SEC EDGAR

accession 0001193125-22-198101

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.